Cannabis Disorder
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and ICD-10 as the continued use of cannabis despite clinically significant impairment.
Cluster Number:
Wiki Number: W033
Diagnosis: Cannabis (Marijuana) Use Disorder
US Patients:
World Patients :
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: develops tolerance, requiring increased use, 15% of daily users become addicted
Progression: withdrawal, tolerance, use of time, cravings;1/3 of users transition to schizophrenia
Causes:
Medications: None with consistent, positive results; 9% of users become dependent.
Therapies:
Youtube Video: Cannabis Use Disorder
Amazon or Library Book: Quitting Weed
Click the book to link or order from Amazon.
Support Group: marijuana-anonymous/find-a-meeting; Online
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Reseau canadien pour les traitements de l'humeur et de l'anxiete (CANMAT) 2023 : Mise a jour des lignes directrices cliniques pour la prise en charge du trouble depressif majeur chez les adultesby Raymond W Lam on May 7, 2024
CONCLUSIONS: The CANMAT 2023 updated guidelines provide evidence-informed recommendations for the management of MDD, in a clinician-friendly format. These updated guidelines emphasize a collaborative, personalized, and systematic management approach that will help optimize outcomes for adults with MDD.
- Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathwaysby Run Ma on May 7, 2024
Liver fibrosis has become a serious public health problem that can develop into liver cirrhosis and hepatocellular carcinoma and even lead to death. Cannabidiol (CBD), which is an abundant nonpsychoactive component in the cannabis plant, exerts cytoprotective effects in many diseases and under pathological conditions. In our previous studies, CBD significantly attenuated liver injury induced by chronic and binge alcohol in a mouse model and oxidative bursts in human neutrophils. However, the...
- Assessment of the effect of cannabis use before partnered sex on women with and without orgasm difficultyby Suzanne Mulvehill on May 7, 2024
CONCLUSION: Cannabis-related treatment appears to provide benefit to women who have female orgasm difficulties or dysfunction.
- Multi-level prediction of substance use: Interaction of white matter integrity, resting-state connectivity and inhibitory control measured repeatedly in every-day lifeby Valentine Chirokoff on May 6, 2024
Substance use disorders are characterized by inhibition deficits related to disrupted connectivity in white matter pathways, leading via interaction to difficulties in resisting substance use. By combining neuroimaging with smartphone-based ecological momentary assessment (EMA), we questioned how biomarkers moderate inhibition deficits to predict use. Thus, we aimed to assess white matter integrity interaction with everyday inhibition deficits and related resting-state network connectivity to...